Pekin Hardy Strauss’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $239K | Sell |
9,923
-2,392
| -19% | -$62.6K | 0.02% | 433 |
|
|
2026
Q1 | $346K | Sell |
12,315
-1,315
| -10% | -$35K | 0.04% | 351 |
|
|
2025
Q4 | $339K | Buy |
13,630
+2,921
| +27% | +$73.7K | 0.03% | 339 |
|
|
2025
Q3 | $273K | Sell |
10,709
-1,350
| -11% | -$33.3K | 0.03% | 344 |
|
|
2025
Q2 | $292K | Buy |
12,059
+1,880
| +18% | +$43.8K | 0.03% | 304 |
|
|
2025
Q1 | $258K | Sell |
10,179
-11,716
| -54% | -$307K | 0.03% | 299 |
|
|
2024
Q4 | $581K | Sell |
21,895
-6,000
| -22% | -$163K | 0.07% | 228 |
|
|
2024
Q3 | $807K | Buy |
27,895
+800
| +3% | +$23.3K | 0.1% | 173 |
|
|
2024
Q2 | $758K | Buy |
27,095
+2,090
| +8% | +$57.5K | 0.1% | 170 |
|
|
2024
Q1 | $694K | Sell |
25,005
-1,161
| -4% | -$32.2K | 0.09% | 179 |
|
|
2023
Q4 | $753K | Sell |
26,166
-37,458
| -59% | -$1.13M | 0.11% | 161 |
|
|
2023
Q3 | $2.11M | Sell |
63,624
-3,570
| -5% | -$126K | 0.33% | 81 |
|
|
2023
Q2 | $2.46M | Sell |
67,194
-2,633
| -4% | -$102K | 0.27% | 74 |
|
|
2023
Q1 | $2.85M | Sell |
69,827
-2,569
| -4% | -$111K | 0.38% | 62 |
|
|
2022
Q4 | $3.71M | Sell |
72,396
-1,958
| -3% | -$93.9K | 0.51% | 54 |
|
|
2022
Q3 | $3.25M | Buy |
74,354
+39
| +0.1% | +$1.9K | 0.52% | 53 |
|
|
2022
Q2 | $3.9M | Buy |
74,315
+1,500
| +2% | +$76.4K | 0.55% | 50 |
|
|
2022
Q1 | $3.77M | Sell |
72,815
-700
| -1% | -$36.3K | 0.47% | 52 |
|
|
2021
Q4 | $4.34M | Buy |
73,515
+1,000
| +1% | +$49.5K | 0.59% | 43 |
|
|
2021
Q3 | $3.12M | Buy |
72,515
+1,093
| +2% | +$48.4K | 0.45% | 62 |
|
|
2021
Q2 | $2.8M | Buy |
71,422
+1,625
| +2% | +$63.2K | 0.39% | 75 |
|
|
2021
Q1 | $2.53M | Buy |
69,797
+3,785
| +6% | +$134K | 0.4% | 66 |
|
|
2020
Q4 | $2.43M | Sell |
66,012
-1,994
| -3% | -$73.1K | 0.42% | 62 |
|
|
2020
Q3 | $2.37M | Buy |
68,006
+4,637
| +7% | +$163K | 0.48% | 53 |
|
|
2020
Q2 | $1.97M | Sell |
63,369
-513
| -0.8% | -$17.4K | 0.43% | 57 |
|
|
2020
Q1 | $1.98M | Sell |
63,882
-2,045
| -3% | -$69.7K | 0.44% | 53 |
|
|
2019
Q4 | $2.45M | Sell |
65,927
-184
| -0.3% | -$6.55K | 0.4% | 62 |
|
|
2019
Q3 | $2.25M | Sell |
66,111
-8,632
| -12% | -$314K | 0.44% | 58 |
|
|
2019
Q2 | $3.07M | Sell |
74,743
-295
| -0.4% | -$11.7K | 0.61% | 40 |
|
|
2019
Q1 | $3.02M | Sell |
75,038
-211
| -0.3% | -$8.45K | 0.24% | 44 |
|
|
2018
Q4 | $3.12M | Buy |
75,249
+14,430
| +24% | +$599K | 0.54% | 41 |
|
|
2018
Q3 | $2.54M | Sell |
60,819
-2,767
| -4% | -$107K | 0.44% | 55 |
|
|
2018
Q2 | $2.19M | Sell |
63,586
-6,867
| -10% | -$235K | 0.42% | 55 |
|
|
2018
Q1 | $2.37M | Sell |
70,453
-395
| -0.6% | -$13.6K | 0.43% | 57 |
|
|
2017
Q4 | $2.44M | Sell |
70,848
-5,187
| -7% | -$177K | 0.44% | 52 |
|
|
2017
Q3 | $2.58M | Sell |
76,035
-9,951
| -12% | -$320K | 0.48% | 50 |
|
|
2017
Q2 | $2.74M | Sell |
85,986
-2,664
| -3% | -$84K | 0.43% | 45 |
|
|
2017
Q1 | $2.88M | Sell |
88,650
-1,702
| -2% | -$53.7K | 0.56% | 40 |
|
|
2016
Q4 | $2.78M | Buy |
90,352
+2,472
| +3% | +$75.5K | 0.25% | 41 |
|
|
2016
Q3 | $2.82M | Buy |
87,880
+1,133
| +1% | +$37.9K | 0.48% | 43 |
|
|
2016
Q2 | $2.9M | Sell |
86,747
-4,545
| -5% | -$145K | 0.64% | 40 |
|
|
2016
Q1 | $2.57M | Sell |
91,292
-8,393
| -8% | -$240K | 0.6% | 41 |
|
|
2015
Q4 | $3.05M | Buy |
99,685
+3,024
| +3% | +$95.1K | 0.69% | 38 |
|
|
2015
Q3 | $2.88M | Sell |
96,661
-1,772
| -2% | -$56.8K | 0.66% | 38 |
|
|
2015
Q2 | $3.13M | Buy |
98,433
+61
| +0.1% | +$1.99K | 0.61% | 37 |
|
|
2015
Q1 | $3.25M | Buy |
98,372
+42,916
| +77% | +$1.36M | 0.6% | 38 |
|
|
2014
Q4 | $1.64M | Sell |
55,456
-485
| -0.9% | -$13.9K | 0.24% | 84 |
|
|
2014
Q3 | $1.57M | Buy |
55,941
+8,295
| +17% | +$233K | 0.27% | 51 |
|
|
2014
Q2 | $1.34M | Buy |
47,646
+22,545
| +90% | +$643K | 0.21% | 54 |
|
|
2014
Q1 | $765K | Buy |
25,101
+3,188
| +15% | +$95.1K | 0.12% | 63 |
|
|
2013
Q4 | $637K | Sell |
21,913
-764
| -3% | -$22.2K | 0.1% | 69 |
|
|
2013
Q3 | $618K | Buy |
22,677
+306
| +1% | +$8.33K | 0.1% | 68 |
|
|
2013
Q2 | $595K | Buy |
+22,371
| New | +$618K | 0.1% | 69 |
|
Other funds holding PFE
Pekin Hardy Strauss's PFE Position: Q2 2026 in Review
Pekin Hardy Strauss reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $62.6K and leaving 9,923 shares worth $239K. The position accounts for 0.02% of the portfolio, ranked #433.
Pekin Hardy Strauss first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.34M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Pekin Hardy Strauss held 9,923 shares of Pfizer worth $239K as of Q2 2026.
- Pekin Hardy Strauss sold 2,392 Pfizer shares in Q2 2026, an estimated $62.6K.
- Pfizer made up 0.02% of Pekin Hardy Strauss's portfolio in Q2 2026, its #433 holding.
- Pekin Hardy Strauss first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Pekin Hardy Strauss's Pfizer position peaked at $4.34M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.